Page 14 - Medication Guide News Today

SEQUENCE, a Phase 3 head-to-head study (study drug open-label and efficacy assessment blinded) compared risankizumab to ustekinumab for the treatment of adult...

/PRNewswire/ -- Today, Danco filed a cert petition asking the Supreme Court to review the Fifth Circuits decision invalidating changes FDA approved to the...

Data presentations explore effects on patient-centric efficacy measures of treatments for patients with depression, and excessive sleepiness associated with obstructive sleep apnea and narcolepsy NEW...

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson will showcase data from its neuropsychiatry portfolio at Psych Congress 2023. The...

Many of us use health and fitness tracking apps to improve our well-being. These apps can be very helpful, but they can also collect lots of information about us. Some of this information may be sensitive, such as our health conditions, habits, and locations. Therefore, there is a growing concern over how these apps handle

Health and fitness tracking apps can help us get in shape, but it's important to understand how apps use personal data, Kurt "The CyberGuy" Knutsson explains.

Rick found strength in the leukemia community.

STOUGHTON, Mass., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutic...

Submissions are supported by two Phase 3 clinical trials demonstrating risankizumab achieved the primary endpoint of clinical remission and key secondary endpoints as an induction and maintenance...

18.08.2023 - CHAPLE is an ultra-rare hereditary disease that can cause potentially life-threatening gastrointestinal and cardiovascular symptoms Approval represents 10th FDA-approved medicine invented by Regeneron With the approval of Veopoz, the ...